Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
Portfolio Pulse from Vandana Singh
Senator Bernie Sanders has vowed to oppose all health agency nominees, including Monica Bertagnolli for NIH director, until the Biden administration presents a plan to lower prescription drug prices. Sanders has urged the HHS to address the high cost of Eisai Co Ltd and Biogen Inc's Alzheimer's treatment Leqembi.
June 14, 2023 | 5:52 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bernie Sanders' opposition to health agency nominees and call for lower drug prices may put pressure on Biogen's Alzheimer's treatment Leqembi.
Senator Sanders' opposition to health agency nominees and demand for a plan to lower drug prices may put pressure on Biogen's Alzheimer's treatment Leqembi. If the administration takes action to address the high cost of Leqembi, it could negatively impact Biogen's revenues and stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Eisai Co Ltd may face pressure to lower the price of its Alzheimer's treatment Leqembi due to Senator Bernie Sanders' opposition to health agency nominees and call for lower drug prices.
Senator Sanders' opposition to health agency nominees and demand for a plan to lower drug prices may put pressure on Eisai Co Ltd's Alzheimer's treatment Leqembi. If the administration takes action to address the high cost of Leqembi, it could negatively impact Eisai's revenues and stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80